In brown adipocytes, adrenergically induced β1-/β3-(Gs)-, α2-(Gi)- and α1-(Gq)-mediated Erk1/2 activation is not mediated via EGF receptor transactivation
(English)Article in journal (Other academic) Submitted
Brown adipose tissue is unusual in utilising the neurotransmitter norepineph- rine to influence cell destiny in ways generally associated with classical growth factors: regulation of cell proliferation, apoptosis, progression of differentiation. These effects are thus mediated through G-protein-coupled receptors; mediation of such stimulation to e.g. Erk1/2 activation is generally accepted to occur through transactivation of the EGF receptor (by external or internal pathways). We have examined here the significance of such transac- tivation in brown adipocytes. Stimulation of mature brown adipocytes with cirazoline (α1-adrenoceptor coupled via Gq), clonidine (α2 via Gi) or CL316243 (β3 via Gs) significantly activated Erk1/2. Pretreatment with the EGF receptor kinase inhibitor AG1478 had, remarkably, no significant effect on Erk1/2 activation induced by any of the adrenergic agonists (although it fully abolished EGF-induced Erk1/2 activation), demonstrating absence of transactivation. Results with brown adipocytes in more proliferative states were not qualitatively different. Joint stimulation of all adrenoceptors with norepinephrine did not result in synergism on Erk1/2 activation or in occur- rence of transactivation. AG1478 action on EGF-stimulated Erk1/2 phos- phorylation showed a sharp concentration-response relationship with an IC50 of approx. 0.3 μM; a minor effect of AG1478 on norepinephrine- stimulated Erk1/2 phosphorylation was clearly nonspecific, occurring suc- cessively and only partially over 3 decades of AG1478 concentrations; cau- tion may therefore be required in interpretation of effects of AG1478 at higher concentrations. Transactivation of the EGF receptor is clearly not a universal prerequisite for coupling of G-protein coupled receptors to Erk1/2 signaling cascades.
Other Biological Topics
Research subject Physiology
IdentifiersURN: urn:nbn:se:su:diva-88574OAI: oai:DiVA.org:su-88574DiVA: diva2:612229
FunderSwedish Cancer Society